NVO and GDRX Related Headlines

Go Back

Aug 18, 2025 12:01PM Mizuho Reiterates Neutral Rating on GoodRx Holdings Inc. (GDRX)
Aug 18, 2025 10:53AM BofA Securities Reiterates Underperform Rating on GoodRx Holdings Inc. (GDRX)
Aug 18, 2025 09:07AM Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers
Aug 18, 2025 09:05AM GoodRx partners with Novo Nordisk to offer Ozempic, Wegovy for $499 monthly

NVO and GDRX Related Press Releases

Go Back

NVO and GDRX Related SEC Filings

Go Back